Scholarlink

Background <p>Ventral hernia repair (VHR) is a common general surgical procedure. While robotic VHR (RVHR) has shown advantages in large, complex hernias, comparative evidence with laparoscopic VHR (LVHR) for smaller defects is limited.</p> Methods <p>We conducted a prospective, real-world evidence study across 12 centers in India. Adults aged 18–65&#xa0;years undergoing primary or incisional VHR with a defect ≤ 5&#xa0;cm requiring mesh placement were included. Primary outcomes were postoperative pain and analgesic use within 14&#xa0;days; secondary outcomes included quality of life (QoL), hospital stay, and perioperative complications.</p> Results <p>A total of 200&#xa0;patients (101 RVHR, 99 LVHR) were analyzed, with comparable baseline characteristics. Defect size was larger in the RVHR group (p &lt; 0.001). Median operative time was longer in RVHR (p &lt; 0.001), while post-anesthesia care unit stay was shorter (p = 0.0026). RVHR was associated with faster recovery, including earlier return to daily activities (median 5 vs. 7&#xa0;days, p &lt; 0.001), fewer analgesic doses (2.55 ± 0.97 vs. 3.25 ± 1.55, p &lt; 0.001), and shorter work restrictions (14 vs. 30&#xa0;days, p = 0.0042). Pain outcomes favored RVHR, with consistently lower Numeric Rating Scale (NRS) scores, greater&#xa0;improvement in&#xa0;PROMIS pain intensity scores at day 14 (p = 0.0072), and more patients reporting low pain intensity (51.5% vs. 27.4%, p = 0.001). QoL improved significantly in RVHR, with higher EQ-5D-3L index and VAS gains at day 14 and 30 (all p &lt; 0.01). Complication rates were low and comparable.</p> Conclusion <p>Compared with LVHR, RVHR offered faster recovery, less pain, reduced analgesic use, and better early QoL, supporting its feasibility and short-term advantages.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Pain and quality of life outcomes following robotic and laparoscopic repair of small-mid sized ventral hernias: insights from the aspire india study

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2026年2月2日

查看全文
  • Vivek Bindal,
  • Pradeep Jain,
  • Randeep Wadhawan,
  • Ashwinikumar Kudari,
  • Sreedhara V. Setty,
  • Udipta Ray,
  • Vijaykumar C. Bada,
  • Vishal Soni,
  • Biswabasu Das,
  • Ramkaran Chaudhary,
  • Naveen Sharma,
  • Dhananjay Pandey,
  • Jayant Gul Mulchandani,
  • Deepa Kizhakke Veetil,
  • Mohamed Shies Sadat,
  • Agnigundala Anusha,
  • Krishna Bharadwaj,
  • Divya Gupta,
  • Akhil Dahiya

摘要

Background

Ventral hernia repair (VHR) is a common general surgical procedure. While robotic VHR (RVHR) has shown advantages in large, complex hernias, comparative evidence with laparoscopic VHR (LVHR) for smaller defects is limited.

Methods

We conducted a prospective, real-world evidence study across 12 centers in India. Adults aged 18–65 years undergoing primary or incisional VHR with a defect ≤ 5 cm requiring mesh placement were included. Primary outcomes were postoperative pain and analgesic use within 14 days; secondary outcomes included quality of life (QoL), hospital stay, and perioperative complications.

Results

A total of 200 patients (101 RVHR, 99 LVHR) were analyzed, with comparable baseline characteristics. Defect size was larger in the RVHR group (p < 0.001). Median operative time was longer in RVHR (p < 0.001), while post-anesthesia care unit stay was shorter (p = 0.0026). RVHR was associated with faster recovery, including earlier return to daily activities (median 5 vs. 7 days, p < 0.001), fewer analgesic doses (2.55 ± 0.97 vs. 3.25 ± 1.55, p < 0.001), and shorter work restrictions (14 vs. 30 days, p = 0.0042). Pain outcomes favored RVHR, with consistently lower Numeric Rating Scale (NRS) scores, greater improvement in PROMIS pain intensity scores at day 14 (p = 0.0072), and more patients reporting low pain intensity (51.5% vs. 27.4%, p = 0.001). QoL improved significantly in RVHR, with higher EQ-5D-3L index and VAS gains at day 14 and 30 (all p < 0.01). Complication rates were low and comparable.

Conclusion

Compared with LVHR, RVHR offered faster recovery, less pain, reduced analgesic use, and better early QoL, supporting its feasibility and short-term advantages.